FDA Counterfeit Bulk Drug Information Requested By Commerce Committee
Executive Summary
The House Commerce Committee wants FDA to provide complete records of agency meetings and actions involving counterfeit bulk drug substances in anticipation of hearings on the agency's foreign inspection program.